• Rafarma to be Acquired by R. & D. Biocogency Laboratories americanpharmaceuticalreview
    August 07, 2020
    Rafarma Pharmaceuticals has reached an agreement to be acquired by R. & D. Biocogency Laboratories. Under the agreed terms, Bio-cogency will acquire majority control of Rafarma Pharmaceuticals upon completion of Biocogency’s transition to GAAP ...
PharmaSources Customer Service